Cargando…
Virtual Screening of Drug-Like Compounds as Potential Inhibitors of the Dengue Virus NS5 Protein
Dengue virus (DENV) is the causative agent of dengue fever. Annually, there are about 400 million new cases of dengue worldwide, and so far there is no specific treatment against this disease. The NS5 protein is the largest and most conserved viral protein among flaviviruses and is considered a ther...
Autores principales: | García-Ariza, Leidy L., Rocha-Roa, Cristian, Padilla-Sanabria, Leonardo, Castaño-Osorio, Jhon C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867075/ https://www.ncbi.nlm.nih.gov/pubmed/35223766 http://dx.doi.org/10.3389/fchem.2022.637266 |
Ejemplares similares
-
Antiviral Activity of an Indole-Type Compound Derived from Natural Products, Identified by Virtual Screening by Interaction on Dengue Virus NS5 Protein
por: García-Ariza, Leidy Lorena, et al.
Publicado: (2023) -
Inhibitors compounds of the flavivirus replication process
por: García, Leidy L., et al.
Publicado: (2017) -
In Vitro Inhibition of Replication of Dengue Virus Serotypes 1–4 by siRNAs Bound to Non-Toxic Liposomes
por: Rodriguez-Salazar, Carlos Andrés, et al.
Publicado: (2022) -
Structure-Based Virtual Screening: Identification of a Novel NS2B-NS3 Protease Inhibitor with Potent Antiviral Activity against Zika and Dengue Viruses
por: Shin, Hye Jin, et al.
Publicado: (2021) -
Molecular Docking Based Screening of Plant Flavonoids as Dengue NS1 Inhibitors
por: Qamar, Muhammad Tahir ul, et al.
Publicado: (2014)